We are live on ! Find out more
PCM

Pavaki Capital Management Portfolio holdings

AUM $287M
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$235M
AUM Growth
-$19.8M
Cap. Flow
+$10.3M
Cap. Flow %
4.36%
Top 10 Hldgs %
50.47%
Holding
162
New
31
Increased
16
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$13.2M
2
EWS icon
iShares MSCI Singapore ETF
EWS
+$1.69M
3
ESPR
Esperion Therapeutics
ESPR
+$1.3M
4
B
Barrick Mining
B
+$1.27M
5
NAMS icon
NewAmsterdam Pharma
NAMS
+$1.19M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$8.8M
2
SPRY icon
ARS Pharmaceuticals
SPRY
+$5.71M
3
OGN icon
Organon & Co
OGN
+$3.01M
4
ROIV icon
Roivant Sciences
ROIV
+$868K
5
ALT icon
Altimmune
ALT
+$778K

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.44%
2 Healthcare 20.32%
3 Materials 13.21%
4 Energy 8.84%
5 Technology 4.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FISV
126
Fiserv Inc
FISV
$24.1B
$167K 0.07%
3,000
– –
NVO
127
Novo Nordisk
NVO
$168B
$165K 0.07%
4,500
– –
MARA icon
128
Marathon Digital Holdings
MARA
$4.54B
$163K 0.07%
+20,000
New +$181K
QURE icon
129
uniQure
QURE
$1.78B
$160K 0.07%
9,810
– –
ENIC icon
130
Enel Chile
ENIC
$5.88B
$158K 0.07%
40,000
– –
SSO icon
131
PUT
ProShares Ultra S&P500
SSO
$8.55B
$156K 0.07%
3,000
– –
AIRO
132
AIRO Group Holdings
AIRO
$221M
$152K 0.06%
+20,000
New +$208K
PEB icon
133
Pebblebrook Hotel Trust
PEB
$2.11B
$152K 0.06%
12,000
– –
OSK icon
134
Oshkosh
OSK
$8.01B
$147K 0.06%
1,000
– –
RMAX
135
DELISTED
RE/MAX Holdings
RMAX
$144K 0.06%
25,000
– –
AIQ icon
136
PUT
Global X Artificial Intelligence & Technology ETF
AIQ
$10.4B
$140K 0.06%
3,000
– –
STLA icon
137
Stellantis
STLA
$12.8B
$140K 0.06%
+20,000
New +$168K
HPK icon
138
HighPeak Energy
HPK
$993M
$138K 0.06%
+20,000
New +$105K
EGO icon
139
Eldorado Gold
EGO
$9.93B
$137K 0.06%
4,000
– –
CASS icon
140
Cass Information Systems
CASS
$684M
$132K 0.06%
3,000
– –
VKTX icon
141
Viking Therapeutics
VKTX
$4.03B
$130K 0.06%
4,000
– –
NUVB icon
142
Nuvation Bio
NUVB
$1.99B
$129K 0.05%
+30,000
New +$167K
DLNG icon
143
Dynagas LNG Partners
DLNG
$139M
$128K 0.05%
30,000
– –
FMAO icon
144
Farmers & Merchants Bancorp
FMAO
$472M
$128K 0.05%
+5,000
New +$130K
GROY icon
145
Gold Royalty Corp
GROY
$704M
$125K 0.05%
35,000
– –
AGNC icon
146
AGNC Investment
AGNC
$11B
$120K 0.05%
12,000
– –
LEGN icon
147
Legend Biotech
LEGN
$3.84B
$114K 0.05%
6,305
+5
+0.1% +$95
WVE icon
148
Wave Life Sciences
WVE
$735M
$109K 0.05%
+15,000
New +$195K
FSK icon
149
FS KKR Capital
FSK
$3.07B
$102K 0.04%
+10,000
New +$125K
AKO.B icon
150
Embotelladora Andina Series B
AKO.B
$4.69B
$101K 0.04%
4,000
– –
3 4 5
6
7

Similar funds

OCM
Ogborne Capital Management San Francisco, California $287M AUM 14.05% 1-Year Est. Return
RSC
Red Spruce Capital Berwyn, Pennsylvania $287M AUM 38.81% 1-Year Est. Return
MC
Metavasi Capital Larchmont, New York $287M AUM 97.9% 1-Year Est. Return
QFW
QTR Family Wealth Lake Mary, Florida $287M AUM 40.55% 1-Year Est. Return
SRWM
Shira Ridge Wealth Management Larkspur, California $287M AUM 23.34% 1-Year Est. Return
ORC
O'Rourke & Company Boston, Massachusetts $287M AUM 23.01% 1-Year Est. Return
MPAM
Murphy Pohlad Asset Management Eden Prairie, Minnesota $287M AUM 38.81% 1-Year Est. Return
AWMT
AAFMAA Wealth Management & Trust Fayetteville, North Carolina $286M AUM 19.57% 1-Year Est. Return

Pavaki Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Pavaki Capital Management held 162 positions worth $235M, down 7.8% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Pavaki Capital Management deployed $10.3M of net new capital in Q1 2026, opening 31 new positions and adding to 16 existing holdings. Its largest new stake was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.

By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 44% a quarter earlier, followed by Healthcare and Materials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $8.8M trimmed.

  • Pavaki Capital Management's largest Q1 2026 buy was iShares MSCI Singapore ETF: 60,000 shares worth $1.69M.
  • Pavaki Capital Management added most to Chevron in Q1 2026, an estimated $13.2M increase.
  • Pavaki Capital Management's biggest Q1 2026 reduction was Regeneron Pharmaceuticals, cutting an estimated $8.8M.
  • Pavaki Capital Management fully exited Roivant Sciences in Q1 2026, selling an estimated $868K.
  • Pavaki Capital Management's ten largest holdings make up 50% of its $235M portfolio in Q1 2026.
  • Pavaki Capital Management opened 31 new positions and closed 6 in Q1 2026.
  • Pavaki Capital Management's portfolio value fell 7.8% quarter-over-quarter to $235M.

Based on Pavaki Capital Management's 13F filing for Q1 2026, filed 7 Aug 2026.